Work for SCYNEXIS, Inc.?

Claim Your Profile

SCYNEXIS, Inc. Logo Image

SCYNEXIS, Inc.

SCYNEXIS, Inc. Banner Image

About SCYNEXIS, Inc.

11-50 Employees
Based in Jersey City, New Jersey

SCYNEXIS, Inc. (NASDAQ: SCYX) is a biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant. Their lead candidate, ibrexafungerp (formerly known as SCY-078), is a broad-spectrum, IV/oral antifungal agent representing a novel therapeutic class, in late stage development for multiple indications, ranging from vaginal yeast infections to life-threatening fungal infections in hospitalized patients. The SCYNEXIS team has deep expertise in anti-infective drug development and marketing, which can be leveraged to advance ibrexafungerp from clinical development to commercialization.

Ticker:
SCYX
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Drug Manufacturers - Other (See More Drug Manufacturers - Other Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol